Accelerating Clinical Development In The Asia-Pacific Region

Japan and China are the 2nd and 3rd largest pharmaceutical market with different market dynamics and promising opportunities. Are you planning to expand your drug development and capture Asia key markets potential? Are you familiar with the regulatory environment and process difference in these key countries?

We invite you to join this webinar and learn from industry experts on the market insights and tips for your successful clinical development in Japan and China.

• Pricing System in Japan: First thing you need to consider for Japan market
• The trend of inspection in Japan: How to correspond with PMDA
• Regulatory updates and winning strategies in Greater China